The efficacy of Antipyretic Analgesics administration intravenously for Preventing Rocuronium-Associated Pain/Withdrawal Response: a systematic review and meta-analysis

Table 2 Sensitivity analysis

Comparison		RR (95%CI)	P	I²	Effect model
Total incidence of RAIPWR	Primary analysis	0.52 (0.42,0.66)	P < 0.00001	73%	Random-effects
Total incidence of RAIPWR	Exclude “Uzun 2014” [14]	0.5 (0.43,0.57)	P < 0.00001	0%	Fixed-effects
Administration by IV + VC	Primary analysis	0.56(0.43,0.72)	P < 0.00001	72%	Random-effects
Administration by IV + VC	Exclude “Uzun 2014” [14]	0.51(0.43,0.61)	P < 0.00001	0%	Fixed-effects

ISSN: 1471-2253